TY - JOUR T1 - Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review JF - medRxiv DO - 10.1101/2020.04.17.20069526 SP - 2020.04.17.20069526 AU - S Gupta AU - J Parker AU - S Smits AU - J Underwood AU - S Dolwani Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/05/2020.04.17.20069526.abstract N2 - Aim In addition to respiratory symptoms, COVID-19 can present with gastrointestinal complaints suggesting possible faeco-oral transmission. The primary aim of this review was to establish the incidence and timing of positive faecal samples for SARS-CoV-2 in patients with COVID-19.Methods A systematic literature review identified studies describing COVID-19 patients tested for faecal virus. Search terms for Medline included ‘clinical’, ‘faeces’, ‘gastrointestinal secretions’, ‘stool’, ‘COVID-19’, ‘SARS-CoV-2’ and ‘2019-nCoV’. Additional searches were done in AJG, Gastroenterology, Gut, Lancet Gastroenterology and Hepatology, The WHO Database, CEBM, NEJM, social media and the NICE, bioRxiv and medRxiv preprints. Data were extracted concerning the type of test, number and timing of positive samples, incidence of positive faecal tests after negative nasopharyngeal swabs and evidence of viable faecal virus or faeco-oral transmission of the virus.Results There were 26 relevant articles identified. Combining study results demonstrated that 53·9% of those tested for faecal RNA were positive. Duration of faecal viral shedding ranged from 1 to 33 days after a negative nasopharyngeal swab with one result remaining positive 47 days after onset of symptoms. There is insufficient evidence to suggest that COVID-19 is transmitted via faecally shed virus.Conclusion There is a high rate of positive PCR tests with persistence of SARS-CoV-2 in faecal samples of patients with COVID-19. Further research is needed to confirm if this virus is viable and the degree of transmission through the faeco-oral route. This may have important implications on isolation, recommended precautions and protective equipment for interventional procedures involving the gastrointestinal tract.Competing Interest StatementThe authors have declared no competing interest.Funding StatementS Gupta is funded by the Wales Cancer Research Centre and Cardiff University J Parker is funded by a Royal College of Surgeons of England Research Fellowship S Smits is funded by Health and Care Research Wales health fellowship (ref HF-17-1352) J Underwood is funded by Medical Research Council (Grant Ref: MR/T023791/1) S Dolwani is Chief Investigator of the CONSCOP2 study funded by the NIHR (HTA Project: NIHR127914) There was no payment or services received from a third party by any of the authors or institutions for any aspect of the submitted work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is a systematic review and all the data analyzed was from the studies included in the review which have been cited in the manuscript. ER -